Eyebright Medical Technology (Beijing) Co., Ltd.

SHSE:688050 Rapporto sulle azioni

Cap. di mercato: CN¥15.0b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Eyebright Medical Technology (Beijing) Gestione

Gestione criteri di controllo 4/4

Eyebright Medical Technology (Beijing)'s Il CEO è Jiangbing Xie, nominato in Jun2019, ha un mandato di 5.17 anni. possiede direttamente 12.92% delle azioni della società, per un valore di CN¥ 1.94B. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 3.7 anni e 4.8 anni.

Informazioni chiave

Jiangbing Xie

Amministratore delegato

CN¥1.3m

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEO5.2yrs
Proprietà del CEO12.9%
Durata media del management3.7yrs
Durata media del Consiglio di amministrazione4.8yrs

Aggiornamenti recenti sulla gestione

Recent updates

Returns Are Gaining Momentum At Eyebright Medical Technology (Beijing) (SHSE:688050)

Jul 15
Returns Are Gaining Momentum At Eyebright Medical Technology (Beijing) (SHSE:688050)

Eyebright Medical Technology (Beijing) Co., Ltd.'s (SHSE:688050) 55% Price Boost Is Out Of Tune With Earnings

Jun 10
Eyebright Medical Technology (Beijing) Co., Ltd.'s (SHSE:688050) 55% Price Boost Is Out Of Tune With Earnings

Is Eyebright Medical Technology (Beijing) (SHSE:688050) Using Too Much Debt?

May 13
Is Eyebright Medical Technology (Beijing) (SHSE:688050) Using Too Much Debt?

Eyebright Medical Technology (Beijing)'s (SHSE:688050) Profits May Not Reveal Underlying Issues

Apr 24
Eyebright Medical Technology (Beijing)'s (SHSE:688050) Profits May Not Reveal Underlying Issues

Eyebright Medical Technology (Beijing) Co., Ltd. Just Recorded A 22% Revenue Beat: Here's What Analysts Think

Apr 21
Eyebright Medical Technology (Beijing) Co., Ltd. Just Recorded A 22% Revenue Beat: Here's What Analysts Think

Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050) May Have Run Too Fast Too Soon With Recent 26% Price Plummet

Mar 25
Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050) May Have Run Too Fast Too Soon With Recent 26% Price Plummet

A Look At The Fair Value Of Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050)

Mar 18
A Look At The Fair Value Of Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050)

Returns On Capital Are Showing Encouraging Signs At Eyebright Medical Technology (Beijing) (SHSE:688050)

Mar 01
Returns On Capital Are Showing Encouraging Signs At Eyebright Medical Technology (Beijing) (SHSE:688050)

AMMINISTRATORE DELEGATO

Jiangbing Xie (52 yo)

5.2yrs

Mandato

CN¥1,321,800

Compensazione

Mr. Jiangbing Xie serves as Chairman of the Board and General Manager at Eyebright Medical Technology (Beijing) Co., Ltd. since June 2019 and is its Chief Scientist.


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Jiangbing Xie
Chairman of the Board5.2yrsCN¥1.32m12.92%
CN¥ 1.9b
Baoshan Jia
Deputy GM & National Marketing Director5.2yrsCN¥1.61m0.0036%
CN¥ 538.9k
Zhao Wang
Deputy GM2.2yrsCN¥894.60k0.0042%
CN¥ 633.5k
Yuqian Zhou
Assistant to the GM & Board Secretary2.2yrsCN¥567.30k0.0064%
CN¥ 962.3k

3.7yrs

Durata media

44yo

Età media

Gestione esperta: Il team dirigenziale di 688050 è considerato esperto (durata media dell'incarico 3.7 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Jiangbing Xie
Chairman of the Board5.2yrsCN¥1.32m12.92%
CN¥ 1.9b
Zhao Wang
Deputy GM4.4yrsCN¥894.60k0.0042%
CN¥ 633.5k
Fang Yu
Director5.2yrsNessun datoNessun dato
Haiyan Wang
Independent Director5.2yrsCN¥160.00kNessun dato
Feng Jiang
Independent Director2.6yrsCN¥160.00kNessun dato
Yu Jiao Wang
Employee Supervisor5.2yrsNessun datoNessun dato
Yong Chen
Director2.2yrsNessun datoNessun dato
Lin Liang
Supervisor2.2yrsNessun datoNessun dato

4.8yrs

Durata media

50yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 688050 sono considerati esperti (durata media dell'incarico 4.8 anni).